Skip to content

Search the library by company, product or topic.

↵open↑↓navigateescclose
Made byViz.ai

Viz Platform

Imaging AI and care coordination platform that flags suspected time-critical findings and notifies the treating team on a mobile app.

viz.ai

At a glance

Type
Clinician platform
Platforms
iOS · Android · Web
Who it’s for
Clinicians and physicians
Where it’s available
United States
Sources cited
3
In the library since
24 September 2026
Regulatory status
Modules are cleared individually; see the FDA records for the applicant Viz. Ai, Inc. (K180161 to K250354). No clearance count is given here.As recorded from the regulator or the company, with its attribution.

What it does

The App Store lists the "Viz.ai" app (seller Viz.ai, Inc., category Medical, free, iOS 17 or later) and states that Viz LVO, Viz CTP and Viz ICH are regulated as medical devices and intended for use by trained clinicians.

What the company says

The company’s own statements, attributed to it and not presented as established fact.

The company says the Viz Platform is deployed in 2,000 hospitals in the United States. The company has also used the names Viz.ai One and Viz.ai enterprise platform. In May 2026 it launched Viz Pulmonary Suite for COPD, lung nodules and pulmonary embolism on the platform; the release cites a single-centre study for Viz PE and notes that results may not be generalizable.

More of Recent HealthTech